FORT WORTH, Texas—Q Global Capital Management, LP, a significant stakeholder in ModivCare Inc (NASDAQ:MODV), recently reported a series of transactions involving the company’s common stock. According to the latest SEC filing, the company sold shares worth a total of approximately $5.4 million. These sales occurred at prices ranging from $6.53 to $11.81 per share, with the stock currently trading near its 52-week low of $6.32. InvestingPro The analysis shows that the stock is currently undervalued, with analysts setting price targets between $10 and $42.

The transactions were executed on January 10 and January 13, 2025, and resulted in the reduction of Q Global’s holdings in ModivCare. Despite these sales, Q Global also acquired additional shares worth approximately $48,384 at an average price of $12.61 per share on January 10.

Q Global Capital Management, along with Q Global Advisors, LLC, Renegade Swish, LLC, and Geoffrey Raynor, maintain a significant ownership stake in ModivCare, as shown in their filing status as ten percent who are the owners. The transactions were made under the direct ownership of Q Global Capital Management.

In other recent news, ModivCare Inc. announced third quarter earnings, reporting revenue of $702 million and an adjusted EBITDA of $43 million. Despite a net loss of $27 million, the company revised its adjusted EBITDA guidance for 2024 to between $170 million and $180 million. Additionally, ModivCare projects a 10% increase in adjusted EBITDA for 2025, driven by membership growth and new contracts.

The company also unveiled significant changes to its board, with Christopher S. Shackelton and Rahul Samant stepping down. The vacancies were immediately filled by Leslie V. Norwalk as the new Interim Chair of the Board and the addition of two new independent directors, Craig Barbarosh and Neal Goldman.

Additionally, Lake Street Capital Markets significantly reduced the price target for ModivCare shares to $10.00, a sharp decline from the previous $30.00 target, while also reaffirming a Buy rating on the stock. This change follows ModivCare’s decision to withdraw its financial guidance for the years 2024 and 2025 due to changes in its business and the broader market environment.

Finally, ModivCare secured $75 million in additional investment from some of its creditors, who also agreed to provide relief from financial covenants related to the company’s debt ratios. This financial buffer is expected to maintain the liquidity of ModivCare until the middle of the year 2025, allowing the company the flexibility to implement strategic actions, which may include the sale of assets. These recent developments reflect the company’s strategic position and operational efficiency.

This article was created with the support of AI and reviewed by an editor. For more information see our T&C.